JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2016, Vol. 30 ›› Issue (6): 42-45.doi: 10.6040/j.issn.1673-3770.0.2016.076

Previous Articles     Next Articles

The treatment experience on osteoradionecrosis of skull base with nasopharyngeal carcinoma after radiotherapy.

WANG Yaning1, GENG Bo2, LI Baiyan2, CUI Chaoyang2, WANG Qirong2   

  1. 1. Taishan Medical University, Taian 271016, Shandong, China;2. Department of Otorhinolaryngology, Qianfoshan Hospital of Shandong Province, Jinan 250014, Shandong, China
  • Received:2016-03-01 Online:2016-12-16 Published:2016-12-16

Abstract: Objective To investigate the clinical treatment strategies of osteoradionecrosis of skull base(ORN)in the patients with nasopharyngeal carcinoma(NPC)after radiotherapy. Methods All patients(n=11)diagnosed as NPC and osteoradionecrosis of the skull base were studied retrospectively with their clinical manifestations, diagnoses, therapies and prognoses. Results In the NORN group, 2 cases died of intracranial and lung infections respectively1year after the treatment. Out of the 5 survivors, 3 was in the stationary state(one was followed up five years,1 three years and 1 one year)and the other 2 were presented with repeated infection and expansion of the osteoradionecrosis lesion(one was followed up one year, one eight months). In the TORN group, 3 patients had localized necrosis, of which one had complete epithelialization(followed up 3 years)and two had continuous seepage( followed up 1 and 3 years separately), and they were not presented with expansion of the osteoradionecrosis lesion. The last patient died of massive expistaxis due to internal carotid blowout. Three patients of the group executed responsibility vascular embolization. Conclusion For ORN, early and complete clean up of the necrotic tissue by endoscopy is an effective method. Responsibility vascular embolozation can not only avoid excessive bleeding and reduce mortality, but also reduce the operation risk and thoroughly clean the necrosis.

Key words: Nasopharyngeal carcinoma, Osteoradionecrosis, infection, Treatment outcome, Computed tomography

CLC Number: 

  • R739.63
[1] Fajardo L F.Basic mechanisms and general morphology of radiation injury[J].Semin Roentgenol, 1993, 28(4):297-302.
[2] Riva G, Boita M, Ravera M, et al. Nasal cytological changes as late effects of radiotherapy for nasopharyngeal cancer[J]. Am J Rhinol Allergy, 2015, 29(2):41-45. doi:10.2500/ajra.2015.29.4156.
[3] Dambrain R.The pathogenesis of osteoradionecrosis[J].Rev Stomatol Chir Maxillofac, 1993, 94(3):140-147.
[4] Nagorsky M J. Radiation injury to the temporal bone[J].Clin Plast Surg, 1993, 20(3):531-534.
[5] Ramsden R T, Bulman C H, Lorigan B P. Osteoradionecrosis of thetemporalbone[J]. J Laryngol Otol, 1975, 89(9):941-955.
[6] 闵华庆.鼻咽癌研究[M].广州:广东科技出版社,1998:303-306.
[7] 林枫,虞幼军,陈伟雄,等. 放射性颞骨骨坏死的临床分型和广泛性骨坏死的治疗(附27例临床分析)[C]. 中国抗癌协会头颈肿瘤专业委员会2011国际暨全国第十一届头颈肿瘤学术大会论文汇编, 2011:9.
[1] LIN Xiaoxue, LIN Baorui, LI Peishan, LU Biaoqing. Application of electronic nasopharyngoscopy combined with narrow band imaging in traditional Chinese medicine syndrome differentiation of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 40-46.
[2] WANG Sheng, LI Yindan, YANG Jinji. The role of microRNA in nasopharyngeal carcinoma and its research progress [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 125-131.
[3] QIU Qianhui, XIAO Xuping, YANG Qintai, YE Jing, DENG Zeyi, WANG Desheng, TAN Guolin, JIANG weihong,. Expert consensus on clinical management recommendations for carotid blowout syndrome secondary to NPC treatment [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 1-18.
[4] WANG Siquan, ZHU Hongshen, ZHANG Xiaobin, ZHAO Zhouyang, MA Yue, YANG Yimei, HUANG Lijin. Analysis of factors associated with stroke and cranial nerve palsy after unilateral internal carotid artery embolization in patients with nasopharyngeal carcinoma after radiotherapy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 19-25.
[5] HUANG Qiao, REN Yi, HOU Tao, LIAO Xingwei, ZHU Zi’ang, ZHAN Xiaolin, LIU Ying, YIN Shihua. Expression of EphB2 in nasopharyngeal carcinoma tissues and its correlation with clinicopathological characteristics [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 26-30.
[6] SUN Chunxiao, WANG Wenqing, YUE Tian, LIU Jisheng. Efficacy analysis of concurrent chemoradiotherapy with high and low cumulative cisplatin doses in the treatment of nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 31-41.
[7] WANG Zaixing, TANG Zhiyuan, LI Dingbo, SHI Zhaohui, ZENG Xianhai, ZHANG Qiuhang. Treatment of internal carotid artery rupture caused by tumor recurrence and skull base osteonecrosis after radiotherapy for nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 49-58.
[8] SUN Fang, XIE Chubo, QIU Qianhui. Retrospective analysis of nutritional indexes and their impact on wound healing in patients with radiation-induced skull base osteoradionecrosis after treatment with nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 59-68.
[9] ZHU Ruikai, WU Jiarong, SUN Fang, XIE Chubo, QIU Qianhui. Computed tomography angiography-based assessment of internal carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma and its associated factors [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 77-84.
[10] QIN Debo, XUE Jiancheng, YANG Wenyue, HU Bing, CHEN Tao, YU Yanping, MENG Qingguo, SUN Huanji, MIAO Beiping, LU Yongtian. Changing the diagnosis and treatment of nasopharyngeal cancer: biomarkers and nasal endoscopic surgery synergise to advance early treatment development [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 85-92.
[11] WU Jiarong, QIU Qianhui. The role and significance of the skull base fascial tissue barrier in endoscopic resection of locally early recurrent nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(4): 108-113.
[12] YANG Ming, LIU Xuexia, ZHANG Hua. Progress of m6A recognition protein IGF2BPs in head and neck cancer [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 153-161.
[13] WU Min, LI Zhengyang, MENG Jie, YE Huiping. Molecular mechanisms of programmed cell death and its role in nasopharyngeal carcinoma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 152-157.
[14] ZHANG Maohua, WEI Rifu, ZHU Zhongshou, LIU Ping, GAO Shang, LI Huifeng. Effect of LncRNA PCAT-1 on the biological behaviour and chemosensitivity of nasopharyngeal carcinoma cells [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 68-76.
[15] HUANG Jiao, PENG Changfu. Progress in objective evaluation of thyroid-related eye disease activity [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 171-178.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!